Log In

    Unicycive Therapeutics Inc. (UNCY)

    Trial Meets Milestone With Complete Enrollment

    ‌
    Robert LeBoyerMedia Inquiries
    Senior Life Sciences Analyst
    March 11, 2024
    Report ID: 26586
    Get Report
    Refer to the full report for the price target, fundamental analysis, and rating.
    Get Report

    Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

    Already Registered? Click the ‘Get Report’ button to login and view the research report.

    Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    ‌
    Unicycive Therapeutics Inc.
    Unicycive Therapeutics Inc.
    Healthcare
    Biotechnology
    Ticker
    UNCY
    Current Price
    $1.04 0.97%
    Market Cap
    $39.1M
    Price Target
    Refer to Report
    Volume
    220.3K
    52wk Range
    $0.47 - $1.8227
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Related Research Reports
    5/14/2024
    ‌
    1Q24 Reported With Pivotal OLC Data Coming In 2Q24
    1Q24 Reported With Pivotal OLC Data Coming In 2Q24 (UNCY)
    0 min read
    3/11/2024
    ‌
    Trial Meets Milestone With Complete Enrollment
    Trial Meets Milestone With Complete Enrollment (UNCY)
    0 min read
    2/14/2024
    ‌
    Initiating Coverage With An Outperform Rating
    Initiating Coverage With An Outperform Rating (UNCY)
    29 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In